A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic interactions between the
hepatitis C NS3 protease inhibitor boceprevir and the calcium channel blockers amlodipine and
diltiazem in healthy volunteers.